Acadian Asset Management
ANRO icon

Acadian Asset Management’s Alto Neuroscience ANRO Stock Holding History

Acadian Asset Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Sell
55,509
-4,567
-8% -$106K ﹤0.01% 1155
2026
Q1 		$1.35M Buy
60,076
+2,530
+4% +$46.9K ﹤0.01% 1074
2025
Q4 		$1.02M Buy
57,546
+43,023
+296% +$542K ﹤0.01% 1112
2025
Q3 		$58K Sell
14,523
-11,954
-45% -$39.6K ﹤0.01% 1620
2025
Q2 		$57K Buy
+26,477
New +$63K ﹤0.01% 1466

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Acadian Asset Management's ANRO Position: Q2 2026 in Review

Acadian Asset Management reduced its Alto Neuroscience (ANRO) stake by 7.6% in Q2 2026, selling an estimated $106K and leaving 55,509 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1155.

Acadian Asset Management first reported a position in ANRO in Q2 2025 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Acadian Asset Management held 55,509 shares of Alto Neuroscience worth $1.46M as of Q2 2026.
  • Acadian Asset Management sold 4,567 Alto Neuroscience shares in Q2 2026, an estimated $106K.
  • Alto Neuroscience made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1155 holding.
  • Acadian Asset Management first reported a position in Alto Neuroscience in Q2 2025 and has held it in 5 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.